What are the risks of investing in PCVX?
P
What are the risks of investing in PCVX?
🦉
Vaxcyte, Inc. (PCVX)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOGrant E. Pickering
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive...
Key Executives
| Name | Title |
|---|---|
| Andrew L. Guggenhime | President & Chief Financial Officer |
| Chris Griffith | Chief Business & Strategy Officer |
| Elvia Cowan | Senior VP of Finance & Chief Accounting Officer |
| Grant E. Pickering | Co-Founder, Chief Executive Officer & Director |
| Harp Dhaliwal | Chief Technical Operations Officer |
| James Wassil | Executive Vice President & Chief Operating Officer |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A